Abstract
Vessel Plus is an open acccess journal, which publishes articles related to vascular diseases, including acute respiratory distress syndrome, aneurysm, atherosclerosis, hypertension, stroke, peripheral vascular or pulmonary vascular diseases, etc.
Highlights
The increase in the number of mitral valve repair operations, with a rise in the number of biological prostheses implanted in younger patients, has resulted in higher incidences of reoperative mitral valve surgery
Unlike Mitraclip therapy, in which the legislative endorsement is based on the results reported from the Endovascular Valve Edge-to-Edge Repair randomized Study (EVEREST)[19], there is poor evidence on the survival benefit in patients who have undergone TMViV/TMViR for deteriorated bioprostheses compared to those who had redo surgery for structural valvular degeneration (SVD) of mitral valve (MV) . [3,14,15,17,19]
With a median echocardiographic follow up of 772.5 days, this study found that postprocedural mitral stenosis (MS) was more common in patients treated with TMViV procedure, while post-procedural mitral regurgitation (MR) was more common in patients treated with TMViR
Summary
The increase in the number of mitral valve repair operations, with a rise in the number of biological prostheses implanted in younger patients, has resulted in higher incidences of reoperative mitral valve surgery. There is currently evidence that the percentage of structural valvular degeneration (SVD) is 85% in patients after previous MV surgery[1]. In these cases, a second mitral valve surgery may be required in 35% of cases within the first 10 years[5,6]. The crossroads is represented between the choice of mitral valve reoperation using a standard surgical approach or, alternatively, the transcatheter mitral valve implantation procedure. Given the high risk and prohibitive operative mortality for reoperation after mitral valve replacement operation (Re-MVRpl) or mitral valve repair procedure (Re-MVRp), the search for an alternative to the standard surgical approach is both judicious and desirable
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
